“showed a trend”

Based on either the OGM or karyotyping results, MYC rearrangements showed a trend towards hyperdiploidy (46.2% vs. 11.8%, P = 0.09).

After adjustment mRS at day 90 still showed a trend for lower disability scores in the overlap group (3 IQR 1-5 vs. 3 IQR 1-6, p = 0.09).

Multivariable analyses, run separately in AML and ALL, showed a trend toward higher relapse incidence with RIC in comparison to MAC in AML (hazard ratio (HR) 1.34, p = 0.09), and no difference in both AML and ALL in terms of non-relapse mortality (NRM) chronic GVHD and leukemia-free survival.

The feature E showed a trend towards explaining more variance ( p = 0.09 for the BOLD increases; and p = 0.03 for the BOLD decreases) ( Fig. 5 B and D).

baseline EDSS showed a trend toward significance: r = −0.32, p = 0.09).

No significant differences were found for dyslipidemia or autoimmune thyroid disorders, though Graves’ disease showed a trend (1.50% vs. 0.89%, p = 0.090). 3.2.4.

On the other hand, ALDH1- positivity showed a trend for 5-year relapse in univariate analysis (P=0.090).

Higher EVD volumes showed a trend to more secondary infarctions ( p = 0.09), whereas higher LD volumes were associated with less secondary infarctions ( p = 0.009).

After DRC attendance, the annual change in HbA 1c remained similar in those who had additional CKD etiologies (−0.89 vs −0.37 mmol/mol per year; P =.60); in those with T1D, it showed a trend toward flattening (−2.66 vs −1.30 mmol/mol per year; P =.09); and in those with T2D, it changed significantly from a negative to a positive trajectory (−1.26 vs 0.25 mmol/mol per year; P =.003).

The exposure 2 group showed a trend to higher total PTB < 37 weeks compared with the pre-pandemic group (70.3% vs 67.1%; aRR 1.05 95% CI 0.98–1.10, p = 0.09) (Supplementary Table 3 ).

Analysis of the incremental AUC from OGTTs performed 4 wk earlier (week 11) showed a trend for better glucose tolerance in GLU + GAL–fed females than in GLU-fed females ( P = 0.09; Figure 4 A , B ).

75.0 ± 6.7 mg/d l , P <0.05) and the ALB level showed a trend to be lower after treatment (2.63 ± 0.11 vs. 2.79 ± 0.09 g/d l , P =0.09) than before treatment ( Fig. 1 ).

CXCl‐9, the chemokine that mediates lymphocytic infiltration to the focal sites and suppresses tumor growth, also showed a trend toward upregulated expression (10.1‐fold, P = 0.09).

The interaction between the BCAAs and Arg tended to influence the concentrations of IgA ( P = 0.059) and IgG ( P = 0.069), and the orthogonal contrast between the BCAA and the Control groups showed a trend to a higher concentration of IgA in the BCAA group as compared with the control group ( P = 0.09) while the other contrasts regarding IgG were not significant.

reported that in patients with less than three distant metastases, TRT significantly improved the PFS (HR 2.02, P=0.003) and also showed a trend of improving OS (HR 1.55, P=0.09).

The analysis also showed a trend toward a possible association between persistent headache and depressive symptoms (univariate analysis with an OR of 8.000 [range: 0.725–88.226]; p = 0.090).

For Model 2 a sensitivity analysis of biopsy type (Table 3 ) showed that first TCMR on a for‐cause biopsy was a significant correlate of death‐censored and all‐cause graft loss, while first TCMR on a surveillance biopsy showed a trend ( p = .09) toward an increased risk of death‐censored allograft loss and no significant association with all‐cause allograft loss after adjustment for baseline covariates, DGF, and ABMR.

Echocardiographic parameters While LV ejection fraction showed a trend towards non-significant improvement after LBBP and HBP (58.3 ± 5.8% to 60.3 ± 4.9%, p = 0.09; 59.3 ± 6.4% to 61.5 ± 3.8%, p = 0.08, respectively), RVP group showed a non-significant reduction (61.2 ± 4% to 58.7 ± 8.2%, p= 0.08) during follow-up.

endoscopic) and arytenoid removal showed a trend toward a higher risk ( p = 0.09) of temporary and permanent tracheostomy, respectively.

Treatment with large endografts showed a trend toward a higher RT (ΔRT, 0.14 ± 0.06 second vs 0.01 ± 0.03 second; P = .09).

Partial correlations with age, gender, years of education and DZNE site as covariate showed a trend-level correlation of free recall with CSF total-tau ( R = −0.142; P = 0.090) and no correlation with phospho-tau ( R = −0.096; P = 0.250) in amyloid-negative individuals.

In females, LF-fed WT mice show intact memory ( p < 0.001), while HF-fed WT females only showed a trend toward preference for the novel object ( p = 0.09).

Two-way mixed design ANOVA models showed a trend towards a significant interaction in the maximum power of the 30 s rowing test (F = 3.259, p = 0.090), while no significant interaction in other outcomes of the rowing test was observed (i.e., the average power (F = 0.571, p = 0.461), the distance (F = 0.330, p = 0.573), and the predicted time of rowing 500 m (F = 0.272, p = 0.609)) ( Table 2 ).

21%) and showed a trend for longer OS ( P =0.09; 5-year rates: 43% vs . 34%; Figures 2 A to C; Online Supplementary Table S4 ).

When calculated as a categorized variable, it appears that acute coronary syndrome (ACS) patients with higher TyG index levels may have a higher incidence rate of MACE [hazard ratio (HR): 2.09, 95% CI 1.68–2.62, I 2 = 87%, P < 0.00001], whereas chronic coronary syndrome (CCS) or stable CAD patients with higher TyG index levels showed a trend towards an increased incidence rate of MACE (HR: 1.24, 95% CI 0.96–1.60, I 2 = 85%, P = 0.09).